Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: Comparison of different methods of evaluation

Chest

Volumn 136, Issue 2, 2009, Pages 526-535

  Baughman, Robert P ^a   Shipley, Ralph ^a   Desai, Sujal ^b   Drent, Marjolein ^c   Judson, Marc A ^d   Costabel, Ulrich ^e   Du Bois, Roland M ^b   Kavuru, Mani ^f   Schlenker Herceg, Rozsa ^g   Flavin, Susan ^g   Lo, Kim Hung ^g   Barnathan, Elliot S ^g  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f EAST CAROLINA UNIVERSITY   (United States)

^g CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FORCED EXPIRATORY VOLUME; HUMAN; INTERMETHOD COMPARISON; LUNG FUNCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RADIOLOGIST; RANDOMIZED CONTROLLED TRIAL; SARCOIDOSIS; SCORING SYSTEM; THERAPY EFFECT; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 68849125773     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1876     Document Type: Article

References (37)

1. DeRemee RA. The roentgenographic staging of sarcoidosis: historic and contemporary perspectives. Chest 1983; 83:128-133
2. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. Br Med J 1961; 4:1165-1172
3. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164:1885-1889
4. Pietinalho A, Ohmichi M, Lofroos AB, et al. The prognosis of sarcoidosis in Finland and Hokkaido, Japan: a comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17:158-166
5. Felson B, Morgan WK, Bristol LJ, et al. Observations on the results of multiple readings of chest films in coal miners' pneumoconiosis. Radiology 1973; 109:19-23
6. Judson MA, Gilbert GE, Rodgers JK, et al. The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis. Respirology 2008; 13:97-102
7. Muers MF, Middleton WG, Gibson GJ, et al. A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society Study of Long-Term Corticosteroid Treatment. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:46-56
8. McLoud TC, Epler GR, Gaensler EA, et al. A radiographic classification for sarcoidosis: physiologic correlation. Invest Radiol 1982; 17:129-138
9. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996; 51:238-247
10. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174:795-802
11. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis: American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149-173
12. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20:37-46
13. Cohen J. Weighted kappa: nominal scale agreement with provisions for scaled disagreement or partial credit. Psychol Bull 1968; 70:213-220
14. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134:657-662
15. Paramothayan S, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA 2002; 287:1301-1307
16. Pietinalho A, Lindholm A, Haahtela T et al. Inhaled budesonide for treatment of pulmonary sarcoidosis: results of a double-blind, placebo-controlled, multicentre study. Eur Respir J 1996; 9(suppl):406s
17. Baumann MH, Strange C, Sahn SA. Do chest radiographic findings reflect the clinical course of patients with sarcoidosis during corticosteroid withdrawal? AJR Am J Roentgenol 1990; 154:481-485
18. Swingler GH. Observer variation in chest radiography of acute lower respiratory infections in children: a systematic review. BMC Med Imaging 2001; 1:1
19. Wunderink RG, Woldenberg LS, Zeiss J, et al. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 1992; 101:458-463
20. Meade MO, Cook RJ, Guyatt GH, et al. Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161:85-90
21. Beards SC, Jackson A, Hunt L, et al. Interobserver variation in the chest radiograph component of the lung injury score. Anaesthesia 1995; 50:928-932
22. Swingler GH, du Toit G, Andronikou S, et al. Diagnostic accuracy of chest radiography in detecting mediastinal lymphadenopathy in suspected pulmonary tuberculosis. Arch Dis Child 2005; 90:1153-1156
23. Andronikou S, Brauer B, Galpin J, et al. Interobserver variability in the detection of mediastinal and hilar lymph nodes on CT in children with suspected pulmonary tuberculosis. Pediatr Radiol 2005; 35:425-428
24. Monnier-Cholley L, Carrat F, Cholley BP, et al. Detection of lung cancer on radiographs: receiver operating characteristic analyses of radiologists', pulmonologists', and anesthesiologists' performance. Radiology 2004; 233:799-805
25. Cleveland RH, Schluchter M, Wood BP, et al. Chest radiographic data acquisition and quality assurance in multicenter studies. Pediatr Radiol 1997; 27:880-887
26. Nunes H, Brillet PY, Valeyre D, et al. Imaging in sarcoidosis. Semin Respir Crit Care Med 2007; 28:102-120
27. Muller NL, Mawson JB, Mathieson JR, et al. Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings. Radiology 1989; 171:613-618
28. Morgan RH. Proficiency examination of physicians for classifying pneumoconiosis chest films. AJR Am J Roentgenol 1979; 132:803-808
29. Lawson CC, LeMasters MK, Kawas LG, et al. Reliability and validity of chest radiograph surveillance programs. Chest 2001; 120:64-68
30. Welch LS, Hunting KL, Balmes J, et al. Variability in the classification of radiographs using the 1980 International Labor Organization Classification for Pneumoconioses. Chest 1998; 114:1740-1748
31. Musch DC, Higgins IT, Landis JR. Some factors influencing interobserver variation in classifying simple pneumoconiosis. Br J Ind Med 1985; 42:346-349
32. Ducatman AM, Yang WN, Forman SA. 'B-readers' and asbestos medical surveillance. J Occup Med 1988; 30:644-647
33. Gitlin JN, Cook LL, Linton OW, et al. Comparison of "B" readers' interpretations of chest radiographs for asbestos related changes. Acad Radiol 2004; 11:843-856
34. Battesti JP, Saumon G, Valeyre D, et al. Pulmonary sarcoidosis with an alveolar radiographic pattern. Thorax 1982; 37:448-452
35. Rossman MD, Newman LS, Baughman RP, et al. A double-blind, randomized, placebo-controlled trial of infliximab in patients with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23:201-208
36. Drent M, de Vries J, Lenters M, et al. Sarcoidosis: assessment of disease severity using HRCT. Eur Radiol 2003; 13:2462-2471
37. Oberstein A, von Zitzewitz H, Schweden F, et al. Non invasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:65-72